Skip to main content
. 2015 Oct 18;2015:607364. doi: 10.1155/2015/607364

Table 3.

Odds ratios and 95% confidence intervals for the association between metabolic syndrome and various markers.

Odds ratio (95% CI)
Model I Model II Model III
Adiponectin
 1st quartile 1 1 1
 2nd quartile 0.59 (0.44–0.79) 0.65 (0.44–0.95) 0.66 (0.44–0.99)
 3rd quartile 0.29 (0.21–0.40) 0.58 (0.37–0.89) 0.60 (0.38–0.95)
 4th quartile 0.28 (0.20–0.40) 0.34 (0.23–0.51) 0.30 (0.19–0.46)
HOMA-IR
 1st quartile 1 1 1
 2nd quartile 1.63 (1.11–2.32) 1.62 (1.04–2.52) 1.72 (1.08–2.73)
 3rd quartile 2.88 (2.02–4.10) 2.05 (1.33–3.16) 1.83 (1.16–2.88)
 4th quartile 7.36 (5.19–10.46) 3.88 (2.52–5.97) 3.82 (2.42–6.04)
A/H ratio
 1st quartile 1 1 1
 2nd quartile 0.30 (0.22–0.40) 0.53 (0.35–0.80) 0.52 (0.33–0.83)
 3rd quartile 0.25 (0.18–0.16) 0.41 (0.28–0.60) 0.43 (0.28–0.66)
 4th quartile 0.11 (0.08–0.16) 0.23 (0.15–0.35) 0.25 (0.15–0.40)

CI, confidence interval; HOMA-IR, homeostasis model assessment of insulin resistance; A/H ratio, adiponectin to homeostasis assessment-insulin resistance; MetS, metabolic syndrome; IL-6, interleukin-6.

Model I: adjusted for sex and age.

Model II: adjusted for sex, age, body mass index, smoking status, and low-density lipoprotein cholesterol.

Model III: adjusted for sex, age, body mass index, smoking status, low-density lipoprotein cholesterol, total cholesterol, and high-density lipoprotein cholesterol.